))
Hold the Haldol: Exploring the Role of Cholinergics in Schizophrenia
Manage episode 287011775 series 2866905
İçerik Daniel Fuchs, Gedaliah May, Steven Gamss, Produced by Daniel Miller, Daniel Fuchs, Gedaliah May, Steven Gamss, and Produced by Daniel Miller tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Daniel Fuchs, Gedaliah May, Steven Gamss, Produced by Daniel Miller, Daniel Fuchs, Gedaliah May, Steven Gamss, and Produced by Daniel Miller veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Until now, schizophrenia and other psychotic diseases were consistently treated with heavy duty, anti-dopaminergic, anti-psychotic medications. These drugs- both first and second generation- carry serious and sometimes irreversible adverse effects (think: EPS, NMS, etc.)
In today’s episode, we’ll discuss a groundbreaking phase-2 clinical trial exploring the use of a muscarinic agonist in the treatment of schizophrenia. Worried about DUMBBELLS? So were we! But these researchers have designed a truly elegant cholinergic/anti-cholinergic duet.
This is an exciting article you don’t want to miss out on!
27 bölüm
Paylaş
